FDA OKs emergency use authorization of Aytu BioScience COVID-19 test

US FDA OKs Aytu BioScience (NASDAQ:AYTU) +15% emergency use authorization for the COVID-19 IgG/IgM rapid test cassette distributed by the Company.

This is only the fourth lateral flow COVID-19 rapid serology test authorized by the FDA.

Additionally, more than 1.4 million COVID-19 IgG/IgM rapid tests have been delivered to the Company’s warehouse in San Diego and are available for distribution.

https://seekingalpha.com/news/3578956-fda-oks-emergency-use-authorization-of-aytu-bioscience-covidminus-19-test